Alan Burnett
Prosiectau fel Prif Ymchwiliwr
5 o 5
- Nexus monitoring (01.11.2011 - 31.01.2013)
- Senior Fellowship (01.10.2005 - 30.09.2011)
- Sensitivity of pacritinib in acute myeloid leukaemia (28.07.2013 - 27.04.2014)
- Strengthen and develop scientific and technological excellence in research therapy of leukaemia (01.01.2004 - 28.02.2011)
Prosiectau fel Cyd-Ymchwiliwr
2 o 2
- Role of OGG1 in the pathogenesis of acute myeloid leukaemia (01.04.2009 - 30.09.2011)
- Targets for treatment in AML: Discovery and translation (01.04.2010 - 19.09.2013)
- Targets for treatment in AML: Discovery and translation (20.09.2013 - 01.12.2015)
- Use of microarray to identify the mechanism of developmental disruption induced by over-expression of g-catenin in AML (01.02.2008 - 31.07.2009)
- Wales Cancer Trials Network (01.09.2004 - 31.08.2009)
Thomson Reuters Deutschland GmbH
Zur Giesserei 2
D-76227 Karlsruhe | Germany